1 in 2 Aussie women with breast cancer keeping their hair during chemo with innovative technology

Pinterest LinkedIn Tumblr +

Leading Australian cancer experts are urgently calling for greater access to advanced scalp cooling technology for Australian women undergoing chemotherapy in a bid to reduce the substantial psychological impact of treatment-related hair loss and improve patient quality of life.

Scalp cooling technology works by lowering scalp temperature before, during and after the administration of chemotherapy. The cooling tightens up or constricts blood vessels in the scalp, reducing the amount of chemotherapy reaching the cells of the hair follicles.

According to an article just published in Medical Journal of Australia’s Insight+, up to 65 percent of chemotherapy patients will experience hair loss, which can cause such significant psychological distress that some women are forgoing chemotherapy for fear of losing their hair.2 This has promoted an urgent plea from leading oncology experts to improve access to scalp cooling technology for Australians undergoing chemotherapy.

Article co-author, GenesisCare Medical Oncologist Dr Connie Diakos, said: “Hair loss can often be one of the most distressing side effects of chemotherapy, resulting in depression, anxiety, shame, and loss of confidence.

“Scalp cooling technology has been shown to reduce hair loss in more than half of those undergoing chemotherapy. As such, Cancer Australia have recently updated their guidelines and recommend scalp cooling technology for breast cancer.

“However, there are still significant barriers to accessing scalp cooling technology in Australia, denying many patients the option to choose,” said Dr Diakos.

The most recent figures suggest there are more than 680,000 chemotherapy sessions performed in Australia each year,3 with breast cancer one of the most common women’s cancers requiring this treatment.

Sydney-based mum-to-two and university tutor Annabel, 50, was diagnosed with breast cancer last year, and the stigma associated with chemotherapy-related hair loss was a significant concern.

“My breast cancer diagnosis came as a complete shock. However, it didn’t take me long to shift into solutions mode, and I was determined that cancer would just be a small bump in the road, and I would just get on with my life.

“Your hair and your breasts are a quintessential part of being a woman. I had to leave it to my breast surgeon to decide whether or not I’d keep my left breast, but having access to scalp cooling therapy gave me the choice to try and keep my hair,” Annabel said.

After hearing about scalp cooling from her team at GenesisCare and seeing the results firsthand from a friend who had used it during chemotherapy, she opted to try the technology herself in a bid to save her natural hair.

“While scalp cooling doesn’t work the same for everyone, for me, it was fabulous. In keeping my hair, I maintained a sense of control over who I shared my diagnosis with. It also had a huge psychological benefit in how I saw myself every morning when I looked in the mirror,” said Annabel.

According to McGrath Breast Nurse Elaine Arnold, who has over 12 years’ experience in the oncology care: “A breast cancer diagnosis can affect multiple aspects of a patient’s life and femininity, including their fertility, body, sexual health and their appearance. Being empowered to take back some control and maintain the very visual feature of hair can be critical to maintaining their identity.”

Aurora BioScience and GenesisCare have recently announced a partnership to offer the next generation DigniCap Delta® to all suitable patients undergoing chemotherapy, which will help to improve access to these technologies for Australians living with cancer.

“Scalp cooling technology should be offered as part of standard of care in all medical oncology clinics across the private and public sector for suitable patients and we are delighted to be able to offer DigniCap Delta to our patients at GenesisCare centres,” said Dr Diakos.

“With the significant shift towards a more patient-centred approach to cancer care, it’s important that we not only look at treating the cancer itself, but also focus on the emotional well-being of individuals throughout all stages of the treatment journey.”

DigniCap Delta will be made available at GenesisCare Medical Oncology Centres around the country, including a new centre located on Sydney’s Lower North Shore, set to open later this year.


Source: Aurora Bioscience

References
1. American Cancer Society. Cooling Caps (Scalp Hypothermia) to Reduce Hair Loss. 2020 [May 2021]; Available from: https://www.cancer.org/treatment/treatments-and-side-effects/physical-side-effects/hair-loss/cold-caps.html.
2. Diakos, C., et al. Scalp cooling in integrated model of breast cancer care. MJA Insight+. 2021 [May 2021].
3. Australian institute of Health and Welfare (AIHW), Cancer in Australia 2019, in Cancer Series; No. 119. Cat. No. CAN 123,. 2019: Canberra.
4. Wilson, B.E., et al., Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. The Lancet Oncology, 2019. 20(6): p. 769-780.

Share.

About Author

The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.